FDA issues vision loss warning for GLP-1 drugs
By PBS NewsHour
The Food and Drug Administration issued a new warning on Monday about the risk of vision loss related to popular GLP-1 weight loss and diabetes drugs. Health officials say drugs like Eli Lilly’s Zepbound and Ozempic by Novo Nordisk must add a warning label about the rare disease, which can cause blurred vision or…
Read it in your languageMachine translation by Google of the publisher's page
More in Health
From the blog
How Rich Are These Twilight Cast Members? Ranking Their Net Worths: From Robert Pattinson To Jamie Campbell Bower (Ranked, Lowest To Highest)
How wealthy are the stars of Twilight today? Explore the estimated net worth of the cast, ranked from lowest to…
Heart Of The Beast Worldwide Box Office: Brad Pitt Starrer Poised To Fall Just $5 Million Short Of Its Break-Even Target?
Heart of the Beast starring Brad Pitt is not yet dead at the box office, but its theatrical run is…
The Young And The Restless Once Filmed & Aired An Actress’ Real-Life Facelift Surgery On TV
The Young And The Restless once shocked viewers by airing an actress’s real-life surgery, creating one of the most unusual…










